A detailed history of Ninety One North America, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ninety One North America, Inc. holds 13,734 shares of ABT stock, worth $1.62 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
13,734
Holding current value
$1.62 Million
% of portfolio
0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $1.37 Million - $1.62 Million
13,734 New
13,734 $1.57 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $435,913 - $557,914
-5,693 Reduced 1.97%
283,036 $24.6 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $357,634 - $522,958
5,693 Added 2.01%
288,729 $22.8 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $1.33 Million - $1.48 Million
-16,969 Reduced 5.66%
283,036 $24.6 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $24.6 Million - $26.6 Million
300,005 New
300,005 $25.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ninety One North America, Inc. Portfolio

Follow Ninety One North America, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One North America, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ninety One North America, Inc. with notifications on news.